Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q7T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,125
Award facts
- Contract value 100% obligated
- $14,124.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 9, 2026, for the supply of Vraylar 1.5 mg capsules in a quantity of 30 units. This firm fixed-price delivery order, valued at $14,124.61 with an ultimate completion date of January 12, 2026, was awarded on a non-set-aside, competitive basis. The award represents a task order under Amerisourcebergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Vraylar is a brand-name antipsychotic medication used in the treatment of psychiatric and neurological conditions. The place of performance for this delivery order is Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania, consistent with the company's role as a major pharmaceutical distributor supporting federal medical procurement needs. As a critical vendor in the Defense Health Agency supply chain, Amerisourcebergen maintains extensive capabilities in delivering specialty pharmaceuticals, generic medications, vaccines, and medical supplies across multiple therapeutic domains to military treatment facilities and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9Q7T?
SPE2DR26F9Q7T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9Q7T worth?
The government has obligated $14,125 on SPE2DR26F9Q7T.
Is contract SPE2DR26F9Q7T an order under another contract?
Yes. SPE2DR26F9Q7T is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q7T competed?
The extent of competition for SPE2DR26F9Q7T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award